ALLSTATE LIFE PARTICIPATES IN STUDY TO EVALUATE NEW MEDICAL TECHNOLOGY

Allstate Life Insurance Co., a subsidiary of The Allstate Corp., is participating in the PREPARE (PREVU* Predicts Atherosclerosis Risk and Events) clinical trial, a study with Toronto-based IMI International Medical Innovations Inc. and McNeil Consumer Healthcare, Guelph, Ont. The study evaluates a new medical technology for assessing the risk of coronary artery disease.

Insurance Networking News (http://www.insurancenetworking.com/protected/article.cfm?articleId=3528&pb=ros)